Page last updated: 2024-11-05

iomethin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

iomethin: diagnostic aid in determining malignant melanoma; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID28212
CHEMBL ID2110614
SCHEMBL ID11883123
MeSH IDM0041068

Synonyms (17)

Synonym
n-(7-iodoquinolin-4-yl)-n',n'-dimethylpropane-1,3-diamine
nm-113
1,3-propanediamine, n-(7-iodo-4-quinolinyl)-n',n'-dimethyl-
unii-82l4s53hzf
17127-81-0
iomethin
4-(3-dimethylaminopropylamino)-7-iodoquinoline
82l4s53hzf ,
SCHEMBL11883123
CHEMBL2110614
1,3-propanediamine, n3-(7-iodo-4-quinolinyl)-n1,n1-dimethyl-
quinoline, 4-((3-(dimethylamino)propyl)amino)-7-iodo-
4-((3-(dimethylamino)propyl)amino)-7-iodoquinoline
1,3-propanediamine, n'-(7-iodo-4-quinolinyl)-n,n-dimethyl-
DTXSID90169054
7-iodo-4-(3-dimethylaminopropylamino)quinoline
Q27269337
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]